evidence of an effective new treatment for alzheimer’s would create shock waves across healthcare given the extent of the global need among millions of patients.
but it could also be a major event in geopolitics, given what making progress in this highly complex disease would say about a country’s scientific capabilities.
so it is potentially significant that a chinese company, green valley pharmaceutical, has achieved the rare feat of getting a positive read-out in a phase iii trial in mild-to-moderate alzheimer's disease.
"gv-971 could help diversify the portfolio of treatments for this terrible disease"
full story here: